DJIA 17,084.49 33.74 0.20%
NASDAQ 4,830.47 19.68 0.41%
S&P 500 2,014.89 1.46 0.07%
market minute promo


17.43 0.31 (1.81%)

Quote as of

company name or ticker

Recent Quotes

INSM $17.43 1.81%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $17.29
Previous Close $17.12
Daily Range $16.87 - $17.87
52-Week Range $12.65 - $28.66
Market Cap $1.1B
P/E Ratio -9.06
Dividend (Yield) $0.00 (0.0%)
Volume 359,898
Average Daily Volume 628,185
Current FY EPS -$1.95




Drug Makers

INSMED, INC. (INSM) Description

A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. Website:

News & Commentary Rss Feed

This Week in Biotech: A Double-Dose of Hot Potato

Two pharma giants walk away from collaborations, another investigational drug receives the breakthrough designation, and more M&A activity are this week's biggest biotech stories.

H.C. Wainwright: Time To Buy Insmed

Leerink Chats With Biotech Management, Names 20 Stocks To Buy Now

Oversold Conditions For Insmed

Use Options For a Chance To Buy INSM at a 55% Discount

Insmed's (INSM) CEO Will Lewis on Q2 2015 Results - Earnings Call Transcript

Insmed (INSM) Q2 2015 Results - Earnings Call Webcast

Stocks Hitting 52-Week Highs

Use Options For a Chance To Buy INSM at a 62% Discount

Use Options For a Chance To Buy INSM at a 55% Discount

Morning Market Losers

See More INSM News...

INSM's Top Competitors

INSM $17.43 (1.81%)
Current stock: INSM
AMGN $149.59 (-0.21%)
Current stock: AMGN
GILD $100.65 (-0.16%)
Current stock: GILD
BIIB $269.16 (-3.83%)
Current stock: BIIB